TP0502-Pharmaco-Scintigraphic-Study and Amendment

Clinical trial NCT02306785 · COMPLETED

Trial details

NCT number: NCT02306785
Sponsor: Tillotts Pharma AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2012-10-01
Primary completion: 2013-02-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.